Clinical Trials List
Protocol NumberACT16432
Completed
2021-02-01 - 2024-12-31
Phase II
Terminated3
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 邱仁輝 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
- 馮晉榮 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- 林燕淑 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 賴亦貞 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Pang Chung Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- 姜乃榕 Digestive System Department
- Chien-Jui Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Yao-Chung Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
64 participants
